**Background**
Melanogenesis is a complex biological process where melanin is produced by melanocytes, primarily regulated by the enzyme tyrosinase. Overproduction of melanin leads to various hyperpigmentation disorders, making tyrosinase a primary target for dermatological research. Beyond skin pigmentation, oxidative stress and inflammatory signaling pathways, such as NF-κB and p21, are critical drivers of cellular senescence and neurodegenerative diseases like Alzheimer’s. Finding compounds that can modulate these pathways while maintaining low toxicity is essential for developing therapeutic interventions. In this context, we will introduce a versatile bioactive substance – Kojic acid.
**Definition**
Kojic acid is a substance produced by Aspergillus oryzae that acts as a tyrosinase inhibitor with a Mushroom Tyrosinase IC50 of 182.7 μM. According to the Kojic acid description, it is effective both orally and via transdermal absorption.
**In Vitro and In Vivo Studies**
The Kojic acid biological activity encompasses anti-aging, antimicrobial, antioxidant, and anti-inflammatory effects. In vitro, Kojic acid (1000 μM, 7 days) enhances the cell migration ability of HCEC-B4G12 cells and suppresses the abnormal high expression of p21, galectin 8, and laminin α1, α2, and γ1, while decreasing p-NF-κB protein expression. Furthermore, it alleviates angiogenesis in HUVECs induced by senescent HCEC supernatants. Regarding melanogenesis, Kojic acid (500 or 1000 μM, 72 h) reduces tyrosinase expression in B16-4A5 and HMV-II cells. In mouse B16 cells, it exhibits potent antimelanogenic activity with various IC50 values, including 15.8 μM for the inhibition of alpha-MSH-stimulated melanogenesis. Additionally, it shows nematicidal activity against Meloidogyne incognita with an EC50 of 195.2 μg/mL for mortality.
Kojic acid in vivo studies demonstrate its therapeutic potential in neuroprotection. In a mouse model of Alzheimer’s disease induced by β-Amyloid (1-42), administration of Kojic acid (50 mg/kg, p.o., once daily for 3 weeks) reduced inflammatory markers in the hippocampus, ameliorated glial cell activation, and lowered ROS and lipid peroxidase levels. Safety assessments in JCL-Wistar rats indicated an oral LD50 greater than 2 g/kg. For researchers seeking a reliable Kojic acid supplier, these data highlight its efficacy across multiple disease models. In conclusion, Kojic acid is a multifunctional inhibitor of tyrosinase and inflammatory signaling with significant potential in anti-aging and neuroprotective research.
Keywords
Kojic acid, 501-30-4, Parasite, Tyrosinase, NF-κB, CDK, Nuclear factor-κB, Nuclear factor-kappaB, Cyclin dependent kinase, HCEC-B4G12?cells, B16-4A5 cells, HMV-II cells, β-Amyloid (1-42), human (HY-P1363A)-Induced Mouse Model of Alzheimer’s Disease, Anti-aging activity
References
[1] Wei X, et al. Kojic acid inhibits senescence of human corneal endothelial cells via NF-κB and p21 signaling pathways. Exp Eye Res. 2018 Dec 28;180:174-183.
[2] Burnett C L, et al. Final report of the safety assessment of kojic acid as used in cosmetics[J]. International journal of toxicology, 2010, 29(6_suppl): 244S-273S.
[3] Saeedi M, et al. Kojic acid applications in cosmetic and pharmaceutical preparations. Biomed Pharmacother. 2019 Feb;110:582-593. doi: 10.1016/j.biopha.2018.12.006.
[4] Kim T Y, et al. Nematicidal activity of kojic acid produced by Aspergillus oryzae against Meloidogyne incognita[J]. Journal of Microbiology and Biotechnology, 2016, 26(8): 1383-1391.
[5] Zilles J C, et al. Biological activities and safety data of kojic acid and its derivatives: A review[J]. Experimental dermatology, 2022, 31(10): 1500-1521.
[6] Kai H, et al. Assessment of the effect of arbutin isomers and kojic acid on melanin production, tyrosinase activity, and tyrosinase expression in B16-4A5 and HMV-II melanoma cells[J]. Planta Medica Letters, 2015, 2(01): e39-e41.
[7] Karakaya G, et al. Synthesis and cytotoxic evaluation of kojic acid derivatives with inhibitory activity on melanogenesis in human melanoma cells[J]. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 2018, 18(15): 2137-2148.
[8] Khan A, et al. Antioxidative and Anti-inflammatory Effects of Kojic Acid in Aβ-Induced Mouse Model of Alzheimer’s Disease. Mol Neurobiol. 2021 Oct;58(10):5127-5140.